Lamisil Once (Terbinafine)

Terbinafine blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, a key component of fungal cell membranes. This disruption leads to toxic squalene buildup and loss of membrane integrity, causing fungal cell death.

The dosage and duration of Lamisil Once are determined by the prescribing healthcare professional based on the type and severity of the infection. Patients should follow the prescriber’s instructions and the product label.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil Once.

To request Lamisil Once, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamisil Once (terbinafine) belongs to the allylamine class, which differs from azole antifungals that inhibit lanosterol 14‑α‑demethylase. Terbinafine often requires a shorter treatment course and has a favorable efficacy profile for dermatophyte infections, though choice of therapy depends on the specific infection and patient factors.

Store Lamisil Once at room temperature, below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct heat, and ensure the cap is tightly closed to maintain stability.

Lamisil Once is applied topically to the affected skin area once daily, or as directed by a healthcare professional. The skin should be clean and dry before application, and the treated area should be covered with a thin film of the product.

Serious but rare risks include severe allergic reactions such as angioedema or anaphylaxis, contact dermatitis, systemic hepatotoxicity, and Stevens‑Johnson syndrome. Patients should discontinue use and seek medical attention if they experience signs of a severe reaction.

Lamisil Once should not be used by individuals with a known hypersensitivity to terbinafine or any component of the formulation. It is also contraindicated on broken or severely inflamed skin unless specifically advised by a healthcare professional.